Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature (Q36001819)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature |
scientific article |
Statements
1 reference
Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature (English)
1 reference
Stephen M Ansell
1 reference
Russell J Schilder
1 reference
Peter C Pieslor
1 reference
Leo I Gordon
1 reference
Christos Emmanouilides
1 reference
Katie Vo
1 reference
Myron S Czuczman
1 reference
Thomas E Witzig
1 reference
Charles Theuer
1 reference
Arturo Molina
1 reference
1 December 2004
1 reference
1 reference
5
1 reference
3
1 reference
202-204
1 reference
Identifiers
1 reference
1 reference